Drug
Nepadutant
Nepadutant: highest development phase Phase 2, developed by Menarini. 4 trial records tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Menarini
Trials
| Drug | Phase | Indication |
|---|---|---|
| Nepadutant oral solution NCT01258153 | Phase 2 | Infantile Colic |
| Nepadutant oral solution NCT01309009 | Phase 2 | Infantile Colic |
| Nepadutant NCT01532518 | Phase 2 | Colic |
| Nepadutant NCT00655083 | Phase 1 | Infantile Colic |
Latest
No recent events.
Follow Nepadutant on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.